Start Date
August 31, 2008
Primary Completion Date
March 31, 2010
Exenatide
Subjects randomized to treatment will receive a four month supply of exenatide and will be taught how to administer subcutaneous injections with their exenatide pen and instructed on the following dosing schedule: exenatide - 5 μg twice a day for 7 days, followed by exenatide 10 μg twice a day for the remainder of the four month supply.
Collaborators (1)
Amylin Pharmaceuticals, LLC.
INDUSTRY
Yale University
OTHER